terbutaline has been researched along with peptide yy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomez, G; Greeley, GH; Izukura, M; Kogire, M; Thompson, JC; Uchida, T | 1 |
| Hagan, MM; Moss, DE | 1 |
| Brechet, S; Chayvialle, JA; Claustre, J; Cuber, JC; Dumoulin, V; Plaisancié, P | 1 |
3 other study(ies) available for terbutaline and peptide yy
| Article | Year |
|---|---|
Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs.
Topics: Animals; Dogs; Female; Gastric Acid; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Male; Pentagastrin; Peptide YY; Peptides; Receptors, Adrenergic, beta; Terbutaline; Time Factors | 1990 |
Suppression of peptide YY-induced hyperphagia by terbutaline.
Topics: Adrenergic beta-Agonists; Animals; Dose-Response Relationship, Drug; Eating; Female; Gastrointestinal Hormones; Hyperphagia; Injections; Paraventricular Hypothalamic Nucleus; Peptide YY; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Terbutaline | 1993 |
Involvement of beta1- and beta2- but not beta3-adrenoceptor activation in adrenergic PYY secretion from the isolated colon.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Colon; Dobutamine; Ethanolamines; Isoproterenol; Male; Models, Animal; Organ Culture Techniques; Peptide YY; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Statistics, Nonparametric; Terbutaline; Tetrahydronaphthalenes | 2001 |